Interaction between BDNF and Serotonin: Role in Mood Disorders
The DOI matches its Crossref record; 132 of the 133 references it cites were found in a registry or an index.
Abstract
Brain-derived neurotrophic factor (BDNF) and serotonin (5-hydroxytryptamine, 5-HT) are two seemingly distinct signaling systems that play regulatory roles in many neuronal functions including survival, neurogenesis, and synaptic plasticity. A common feature of the two systems is their ability to regulate the development and plasticity of neural circuits involved in mood disorders such as depression and anxiety. BDNF promotes the survival and differentiation of 5-HT neurons. Conversely, administration of antidepressant selective serotonin reuptake inhibitors (SSRIs) enhances BDNF gene expression. There is also evidence for synergism between the two systems in affective behaviors and genetic epitasis between BDNF and the serotonin transporter genes.
Overview
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“BDNF+/− mice show less dendritic branching as well as dendritic retraction and simplification in CA381 and DG80 and dysregulation of BDNF/TrkB pathways has been reported in MDD and animal models of depression78, 169-171.”
From Dysregulation of adult hippocampal neuroplasticity in major depression: Pathogenesis and therapeutic implications (2022) · cites this paper as [169]
Citations
Cites
Lesch, K.-P., Bengel, D., Heils, A., Sabol, S. Z., Greenberg, B. D., Petri, S., Benjamin, J., Müller, C. R., Hamer, D. H., & Murphy, D. L. (1996) · Science · doi:10.1126/science.274.5292.1527 · Cited by 5,162 · cited 4×
“Analysis of the promoter region of 5-HTT has revealed a polymorphism that results in allelic variation in functional 5-HTT expression (”
BackgroundInfluentialNeurotrophins: Roles in Neuronal Development and Function
Huang, E. J., & Reichardt, L. F. (2001) · Annual Review of Neuroscience · doi:10.1146/annurev.neuro.24.1.677 · Cited by 4,394 · cited 2×
“…survival of peripheral neurons, BDNF is now recognized as a plethoric factor able to regulate a wide repertoire of functions, including neuronal survival, migration, phenotypic differentiation, axonal and dendritic growth, and synapse formation (Huang and Reichardt, 2001; Lewin and Barde, 1996).”
BackgroundRequirement of hippocampal neurogenesis for the behavioral effects of antidepressants
Santarelli, L., Saxe, M., Gross, C., Surget, A., Battaglia, F., Dulawa, S., Weisstaub, N., Lee, J., Duman, R., Arancio, O., et al. (2003) · Science · doi:10.1126/science.1083328 · Cited by 4,321 · cited 2×
“Like BDNF, alterations in 5-HT signaling have demonstrable effects on synaptic plasticity and adult neurogenesis in the hippocampus (Brezun and Daszuta, 1999; Gould, 1999; Santarelli et al, 2003; Djavadian, 2004).”
BackgroundEgan, M. F., Kojima, M., Callicott, J. H., Goldberg, T. E., Kolachana, B. S., Bertolino, A., Zaitsev, E., Gold, B., Goldman, D., Dean, M., et al. (2003) · Cell · doi:10.1016/s0092-8674(03)00035-7 · Cited by 3,888 · cited 2×
“Human subjects carrying the Val66Met SNP exhibit deficits in short-term episodic memory and show abnormal hippocampal activation (”
BackgroundSelf-citationA Neurotrophic Model for Stress-Related Mood Disorders
Duman, R. S., & Monteggia, L. M. (2006) · Biological Psychiatry · doi:10.1016/j.biopsych.2006.02.013 · Cited by 3,375 · cited 7×
“…76 .............................................................................................................................................. Neuropsychopharmacology REVIEWS REVIEW has lagged (Duman and Monteggia, 2006).”
BackgroundInfluentialNestler, E. J., Barrot, M., DiLeone, R. J., Eisch, A. J., Gold, S. J., & Monteggia, L. M. (2002) · Neuron · doi:10.1016/s0896-6273(02)00653-0 · Cited by 3,217
Chronic antidepressant treatment increases neurogenesis in adult rat hippocampus
Malberg, J. E., Eisch, A. J., Nestler, E. J., & Duman, R. S. (2000) · The Journal of Neuroscience · doi:10.1523/jneurosci.20-24-09104.2000 · Cited by 3,111 · cited 1×
“Importantly, antidepressants and the mood stabilizer lithium have been shown to elicit an increase in hippocampal neurogenesis (Chen et al, 2000; Malberg et al, 2000).”
BackgroundTrk Receptors: Roles in Neuronal Signal Transduction
Huang, E. J., & Reichardt, L. F. (2003) · Annual Review of Biochemistry · doi:10.1146/annurev.biochem.72.121801.161629 · Cited by 2,537 · cited 2×
“Binding of mature BDNF (mBDNF) to TrkB triggers tyrosine phosphorylation in its cytoplasmic domain, leading to activation of at least three signaling pathways: MEK–MAPK, phosphatidylinositol-3-kinase (PI3-K) and phospholipase C-g (PLC-g) (Kaplan and Miller, 2000; Chao, 2003; Huang and Reichardt, 2003).”
BackgroundNeurotrophins and their receptors: A convergence point for many signalling pathways
Chao, M. V. (2003) · Nature Reviews Neuroscience · doi:10.1038/nrn1078 · Cited by 2,298 · cited 2×
“Binding of mature BDNF (mBDNF) to TrkB triggers tyrosine phosphorylation in its cytoplasmic domain, leading to activation of at least three signaling pathways: MEK–MAPK, phosphatidylinositol-3-kinase (PI3-K) and phospholipase C-g (PLC-g) (Kaplan and Miller, 2000; Chao, 2003; Huang and Reichardt, 2003).”
BackgroundCREB: A Stimulus-Induced Transcription Factor Activated by A Diverse Array of Extracellular Signals
Shaywitz, A. J., & Greenberg, M. E. (1999) · Annual Review of Biochemistry · doi:10.1146/annurev.biochem.68.1.821 · Cited by 2,134 · cited 2×
“Extensive studies have shown that CREB can be activated via phosphorylation at serine 133 by three signaling pathways: cAMP-PKA, Ca2 + -CaMKIV, and MAPK pathways (Shaywitz and Greenberg, 1999).”
Background
Cited by
Gut–brain axis: How the microbiome influences anxiety and depression
Foster, J. A., & McVey Neufeld, K.-A. (2013) · Trends in Neurosciences · doi:10.1016/j.tins.2013.01.005 · Cited by 2,460
Neufeld, K. M., Kang, N., Bienenstock, J., & Foster, J. A. (2011) · Neurogastroenterology & Motility · doi:10.1111/j.1365-2982.2010.01620.x · Cited by 1,392
Psychobiotics and the manipulation of bacteria–gut–brain signals
Sarkar, A., Lehto, S. M., Harty, S., Dinan, T. G., Cryan, J. F., & Burnet, P. W. J. (2016) · Trends in Neurosciences · doi:10.1016/j.tins.2016.09.002 · Cited by 1,068
“BDNF is reduced in anxiety and depression, a reduction that is reversible through antidepressant action [18].”
Yim, I. S., Tanner Stapleton, L. R., Guardino, C. M., Hahn-Holbrook, J., & Dunkel Schetter, C. (2015) · Annual Review of Clinical Psychology · doi:10.1146/annurev-clinpsy-101414-020426 · Cited by 749
“It interacts with the serotonin system, and the BDNF polymorphism Val66Met has been associated with nonpuerperal depression (Martinowich & Lu 2008).”
BackgroundBDNF-based synaptic repair as a disease-modifying strategy for neurodegenerative diseases
Lu, B., Nagappan, G., Guan, X., Nathan, P. J., & Wren, P. (2013) · Nature Reviews Neuroscience · doi:10.1038/nrn3505 · Cited by 743
Self-citationDuman, R. S., & Voleti, B. (2012) · Trends in Neurosciences · doi:10.1016/j.tins.2011.11.004 · Cited by 714
Barth, C., Villringer, A., & Sacher, J. (2015) · Frontiers in Neuroscience · doi:10.3389/fnins.2015.00037 · Cited by 711
“Martinowich and Lu hypothesize that an increase in extracellular 5-HT, for instance after SSRI use, might increase BDNF levels because inhibition of 5-HTT facilitates serotonergic transmission through 5-HT4,6,7 receptor subtypes (Martinowich and Lu, 2008).”
BackgroundLopresti, A. L., Hood, S. D., & Drummond, P. D. (2013) · Journal of Affective Disorders · doi:10.1016/j.jad.2013.01.014 · Cited by 663
Glutamate and Neurotrophic Factors in Neuronal Plasticity and Disease
Mattson, M. P. (2008) · Annals of the New York Academy of Sciences · doi:10.1196/annals.1418.005 · Cited by 640
5-HT1A receptor function in major depressive disorder
Savitz, J., Lucki, I., & Drevets, W. C. (2009) · Progress in Neurobiology · doi:10.1016/j.pneurobio.2009.01.009 · Cited by 574
The role of 5-HT receptors in depression
Yohn, C. N., Gergues, M. M., & Samuels, B. A. (2017) · Molecular Brain · doi:10.1186/s13041-017-0306-y · Cited by 485
Carver, C. S., Johnson, S. L., & Joormann, J. (2008) · Psychological Bulletin · doi:10.1037/a0013740 · Cited by 484
“Though a large number of genes relate to serotonergic function (Martinowich & Lu, 2007), most of the genetic research discussed here examined the gene that codes the serotonin transporter.”
BackgroundThe impact of environmental enrichment in laboratory rats—Behavioural and neurochemical aspects
Simpson, J., & Kelly, J. P. (2011) · Behavioural Brain Research · doi:10.1016/j.bbr.2011.04.002 · Cited by 480
Neurobiological mechanisms in major depressive disorder
aan het Rot, M., Mathew, S. J., & Charney, D. S. (2009) · Canadian Medical Association Journal · doi:10.1503/cmaj.080697 · Cited by 470
“The ability of the serotonin system to adapt and change in response to various stimuli continues to be influenced by brain-derived neurotrophic factor throughout life.(25)”
BackgroundMolendijk, M. L., Bus, B. A. A., Spinhoven, P., Penninx, B. W. J. H., Kenis, G., Prickaerts, J., Voshaar, R. O., & Elzinga, B. M. (2011) · Molecular Psychiatry · doi:10.1038/mp.2010.98 · Cited by 437
Serum and plasma BDNF levels in major depression: A replication study and meta-analyses
Bocchio-Chiavetto, L., Bagnardi, V., Zanardini, R., Molteni, R., Gabriela Nielsen, M., Placentino, A., Giovannini, C., Rillosi, L., Ventriglia, M., Riva, M. A., et al. (2010) · The World Journal of Biological Psychiatry · doi:10.3109/15622971003611319 · Cited by 435
Tartt, A. N., Mariani, M. B., Hen, R., Mann, J. J., & Boldrini, M. (2022) · Molecular Psychiatry · doi:10.1038/s41380-022-01520-y · Cited by 408
Neuromodulation of Aerobic Exercise—A Review
Heijnen, S., Hommel, B., Kibele, A., & Colzato, L. S. (2016) · Frontiers in Psychology · doi:10.3389/fpsyg.2015.01890 · Cited by 355
Correia, A. S., & Vale, N. (2022) · International Journal of Molecular Sciences · doi:10.3390/ijms23158493 · Cited by 350
Pereira-Miranda, E., Costa, P. R. F., Queiroz, V. A. O., Pereira-Santos, M., & Santana, M. L. P. (2017) · Journal of the American College of Nutrition · doi:10.1080/07315724.2016.1261053 · Cited by 335
“Decreased estrogen reduces the expression and release of brain neurotrophic derived factor and serotonin levels, inducing cell atrophy and modification of synaptic plasticity, increasing cell vulnerability, and consequently triggering depressive disorders [73,74].”
BackgroundIron and mechanisms of emotional behavior
Kim, J., & Wessling-Resnick, M. (2014) · The Journal of Nutritional Biochemistry · doi:10.1016/j.jnutbio.2014.07.003 · Cited by 313
“BDNF promotes the survival and differentiation of serotonin neurons [87], while NE increases BDNF and receptor activation [88].”
BackgroundThe effects of aerobic activity on brain structure.
Thomas, A. G., Dennis, A., Bandettini, P. A., & Johansen-Berg, H. (2012) · Frontiers in Psychology · doi:10.3389/fpsyg.2012.00086 · Cited by 303
“Antidepressant medications cause an increase in BDNF expression, but their effects on VEGF have not yet been clearly demonstrated (Martinowich and Lu, 2008; Ventriglia et al., 2009).”
BackgroundPsychobiotics in mental health, neurodegenerative and neurodevelopmental disorders
Cheng, L.-H., Liu, Y.-W., Wu, C.-C., Wang, S., & Tsai, Y.-C. (2019) · Journal of Food and Drug Analysis · doi:10.1016/j.jfda.2019.01.002 · Cited by 291
Genetics Factors in Major Depression Disease
Shadrina, M., Bondarenko, E. A., & Slominsky, P. A. (2018) · Frontiers in Psychiatry · doi:10.3389/fpsyt.2018.00334 · Cited by 288
Notaras, M., Hill, R., & van den Buuse, M. (2015) · Molecular Psychiatry · doi:10.1038/mp.2015.27 · Cited by 274
BDNF in sleep, insomnia, and sleep deprivation
Schmitt, K., Holsboer-Trachsler, E., & Eckert, A. (2016) · Annals of Medicine · doi:10.3109/07853890.2015.1131327 · Cited by 273
“In addition, it is known that BDNF production is stimulated by serotonin and conversely BDNF increases serotonergic signalling (4,48).”
Backgroundde Vos, C. M. H., Mason, N. L., & Kuypers, K. P. C. (2021) · Frontiers in Psychiatry · doi:10.3389/fpsyt.2021.724606 · Cited by 269
Depression in neurodegenerative diseases: Common mechanisms and current treatment options
Galts, C. P. C., Bettio, L. E. B., Jewett, D. C., Yang, C. C., Brocardo, P. S., Rodrigues, A. L. S., Thacker, J. S., & Gil-Mohapel, J. (2019) · Neuroscience & Biobehavioral Reviews · doi:10.1016/j.neubiorev.2019.04.002 · Cited by 269
Aguilera, M., Arias, B., Wichers, M., Barrantes-Vidal, N., Moya, J., Villa, H., van Os, J., Ibáñez, M. I., Ruipérez, M. A., Ortet, G., et al. (2009) · Psychological Medicine · doi:10.1017/s0033291709005248 · Cited by 265
“Despite recent evidence that serotonin and BDNF systems may be linked at multiple intra- and intercellular levels (Martinowich & Lu, 2008), our results did not find a direct interaction between the two polymorphisms explored.”
Cellular Plasticity Cascades in the Pathophysiology and Treatment of Bipolar Disorder
Schloesser, R. J., Huang, J., Klein, P. S., & Manji, H. K. (2008) · Neuropsychopharmacology · doi:10.1038/sj.npp.1301575 · Cited by 249
“…fundamental processes underlying synaptic and neural plasticity; many of these advances are well covered in accompanying papers (Bear et al, 2008; Martinowich and Lu, 2008; Citri and Malenka, 2008; McClung and Nestler, 2008), and are not discussed in detail Table 1 Putative Roles for Signaling…”
BackgroundEvidence of biologic epistasis between BDNF and SLC6A4 and implications for depression
Pezawas, L., Meyer-Lindenberg, A., Goldman, A. L., Verchinski, B. A., Chen, G., Kolachana, B. S., Egan, M. F., Mattay, V. S., Hariri, A. R., & Weinberger, D. R. (2008) · Molecular Psychiatry · doi:10.1038/mp.2008.32 · Cited by 238
Psychedelics in Psychiatry: Neuroplastic, Immunomodulatory, and Neurotransmitter Mechanisms
Inserra, A., De Gregorio, D., & Gobbi, G. (2021) · Pharmacological Reviews · doi:10.1124/pharmrev.120.000056 · Cited by 232
Prévot, T., & Sibille, E. (2021) · Molecular Psychiatry · doi:10.1038/s41380-020-0727-3 · Cited by 231
“rotrophic support [2], monoaminergic disturbances [3, 4], inflammation [5], immune system dysfunction [6] and”
BackgroundThe Potential Role of Gut Microbiota in Alzheimer’s Disease: From Diagnosis to Treatment
Varesi, A., Pierella, E., Romeo, M., Piccini, G. B., Alfano, C., Bjørklund, G., Oppong, A., Ricevuti, G., Esposito, C., Chirumbolo, S., et al. (2022) · Nutrients · doi:10.3390/nu14030668 · Cited by 225
Albert, P. R., Benkelfat, C., & Descarries, L. (2012) · Philosophical Transactions of the Royal Society B: Biological Sciences · doi:10.1098/rstb.2012.0190 · Cited by 218
Feduccia, A. A., & Mithoefer, M. C. (2018) · Progress in Neuro-Psychopharmacology and Biological Psychiatry · doi:10.1016/j.pnpbp.2018.03.003 · Cited by 217
A brain-centric model of suicidal behavior
Mann, J. J., & Rizk, M. M. (2020) · American Journal of Psychiatry · doi:10.1176/appi.ajp.2020.20081224 · Cited by 214
Sabatinelli, D., Keil, A., Frank, D. W., & Lang, P. J. (2013) · Biological Psychology · doi:10.1016/j.biopsycho.2012.04.005 · Cited by 212
“Considerable progress has been achieved through the use of functional imaging across multiple diagnoses (Etkin and Wager, 2007; Shin and Liberzon, 2010) as well as genetic categorization (Caspi et al., 2010; Martinowich and Lu, 2007).”
Watt, D. F., & Panksepp, J. (2009) · Neuropsychoanalysis · doi:10.1080/15294145.2009.10773593 · Cited by 208
“The neuroendocrine axis and depression: the HPA axis, CRF, glucocorticoids, and BDNF Neuroendocrine alterations constitute a complex and often confusing set of findings in relationship to depression, with many neuroendocrine functions affected in depression, including alterations in the classic HPA stress axis, disrup…”
BackgroundInfluentialAntidepressive Mechanisms of Probiotics and Their Therapeutic Potential
Yong, S. J., Tong, T., Chew, J., & Lim, W. L. (2020) · Frontiers in Neuroscience · doi:10.3389/fnins.2019.01361 · Cited by 204
“As 5-HT promotes BDNF synthesis (Martinowich and Lu, 2008), this presumably explains the concomitant increase in BDNF levels in PFC of rats ameliorated of depression with B.”
BackgroundInfluentialNLRP1 inflammasome contributes to chronic stress-induced depressive-like behaviors in mice
Song, A.-Q., Gao, B., Fan, J.-J., Zhu, Y.-J., Zhou, J., Wang, Y.-L., Xu, L.-Z., & Wu, W.-N. (2020) · Journal of Neuroinflammation · doi:10.1186/s12974-020-01848-8 · Cited by 204
Roullet, F. I., Wollaston, L., deCatanzaro, D., & Foster, J. A. (2010) · Neuroscience · doi:10.1016/j.neuroscience.2010.06.069 · Cited by 200
Biological Aspects of Postpartum Depression
Skalkidou, A., Hellgren, C., Comasco, E., Sylvén, S., & Poromaa, I. S. (2012) · Women's Health · doi:10.2217/whe.12.55 · Cited by 157
“BDNF BDNF, which contributes to regulating neurogenesis and synaptic plasticity, has also been studied in relation to depression [90].”
BackgroundThe Role of BDNF in the Neuroimmune Axis Regulation of Mood Disorders
Jin, Y., Sun, L. H., Yang, W., Cui, R. J., & Xu, S. B. (2019) · Frontiers in Neurology · doi:10.3389/fneur.2019.00515 · Cited by 198
Genetics of borderline personality disorder: Systematic review and proposal of an integrative model
Amad, A., Ramoz, N., Thomas, P., Jardri, R., & Gorwood, P. (2014) · Neuroscience & Biobehavioral Reviews · doi:10.1016/j.neubiorev.2014.01.003 · Cited by 188
Potential Therapeutic Interest of Adenosine A2A Receptors in Psychiatric Disorders
Cunha, R., Ferre, S., Vaugeois, J.-M., & Chen, J.-F. (2008) · Current Pharmaceutical Design · doi:10.2174/138161208784480090 · Cited by 186
“Thus, there is a continuous build-up and strengthening of the ‘neurotrophin hypothesis of depression’ (reviewed in [177,178]) and evidence is accumulating to suggest that A2A receptors are tight controllers of the actions of BDNF, either through transactivation in an acute manner [179–181] or normalization of its sign…”
BackgroundSerotonin Receptors in Hippocampus
Berumen, L. C., Rodríguez, A., Miledi, R., & García-Alcocer, G. (2012) · The Scientific World Journal · doi:10.1100/2012/823493 · Cited by 185
“Several metabotropic effects of serotonin have been related to brain-derived neurotrophic factor (BDNF) expression [144] and BDNF itself promotes the development and function of serotonergic neurons [140].”
BackgroundAssociation of BDNF Val66Met Polymorphism and Brain BDNF Levels with Major Depression and Suicide
Youssef, M. M., Underwood, M. D., Huang, Y.-Y., Hsiung, S.-C., Liu, Y., Simpson, N. R., Bakalian, M. J., Rosoklija, G. B., Dwork, A. J., Arango, V., et al. (2018) · International Journal of Neuropsychopharmacology · doi:10.1093/ijnp/pyy008 · Cited by 183
“The dorsal raphe nucleus was selected as a region of interest for the actions of BDNF because of the role of serotonin and serotonin-synthesizing neurons in mood disorders and suicide, and the reported relationship between BDNF and serotonergic neurons (Martinowich and Lu, 2008).”
Stress and the gut microbiota-brain axis
Molina-Torres, G., Rodriguez-Arrastia, M., Roman, P., Sanchez-Labraca, N., & Cardona, D. (2019) · Behavioural Pharmacology · doi:10.1097/fbp.0000000000000478 · Cited by 179
“Moreover, there are reports that some probiotics can increase plasma levels of the tryptophan, the precursor of serotonin, a neurotransmitter which modules brain functions such as emotion, cognition, motor function and pain processes, as well as neuroendocrine functions such as food ingestion, circadian rhythms and re…”
Pluchino, N., Russo, M., Santoro, A. N., Litta, P., Cela, V., & Genazzani, A. R. (2013) · Neuroscience · doi:10.1016/j.neuroscience.2013.01.025 · Cited by 179
“DHEA administration causes a significant increase in serotonin levels (Svec and Porter, 1997) and there are findings showing the interactions between serotonin, BDNF, and DHEA (Martinowich and Lu, 2008).”
The serotonin-BDNF duo: developmental implications for the vulnerability to psychopathology
Homberg, J. R., Molteni, R., Calabrese, F., & Riva, M. A. (2014) · Neuroscience & Biobehavioral Reviews · doi:10.1016/j.neubiorev.2014.03.012 · Cited by 177
Haase, J., & Brown, E. (2015) · Pharmacology & Therapeutics · doi:10.1016/j.pharmthera.2014.10.002 · Cited by 175
Naoi, M., Maruyama, W., & Shamoto-Nagai, M. (2018) · Journal of Neural Transmission · doi:10.1007/s00702-017-1709-8 · Cited by 173
“BDNF regulates adult neurogenesis in the hippocampus and behavioral and cognitive functions (Martinowich and Lu 2008).”
BackgroundBDNF Impact on Biological Markers of Depression—Role of Physical Exercise and Training
Murawska‐Ciałowicz, E., Wiatr, M., Ciałowicz, M., de Assis, G. G., Borowicz, W., Rocha‐Rodrigues, S., Paprocka‐Borowicz, M., & Marques, A. (2021) · International Journal of Environmental Research and Public Health · doi:10.3390/ijerph18147553 · Cited by 174
“It is involved in mood, behavior, cognition, emotion, motor function, pain sensitivity regulation, and neuroendocrine regulations related to appetite, reproduction, circadian rhythms, and sleep since its metabolite is melatonin, the main regulator of sleep and rhythms [65,132].”
BackgroundInfluentialMassart, R., Mongeau, R., & Lanfumey, L. (2012) · Philosophical Transactions of the Royal Society B: Biological Sciences · doi:10.1098/rstb.2012.0212 · Cited by 170
Arosio, B., Guerini, F. R., Voshaar, R. C. O., & Aprahamian, I. (2021) · Frontiers in Behavioral Neuroscience · doi:10.3389/fnbeh.2021.626906 · Cited by 145
“in brain areas implicated in depression (Martinowich and Lu, 2008).”
Neurotrophins Role in Depression Neurobiology: A Review of Basic and Clinical Evidence
L. Neto, F., Borges, G., Torres-Sanchez, S., A. Mico, J., & Berrocoso, E. (2011) · Current Neuropharmacology · doi:10.2174/157015911798376262 · Cited by 149
“Evidence suggests that BDNF can enhance serotoninergic transmission (review in [238]).”
BackgroundJawahar, M. C., Murgatroyd, C., Harrison, E. L., & Baune, B. T. (2015) · Clinical Epigenetics · doi:10.1186/s13148-015-0156-3 · Cited by 163
Williams, L. M., Gatt, J. M., Schofield, P. R., Olivieri, G., Peduto, A. S., & Gordon, E. (2009) · NeuroImage · doi:10.1016/j.neuroimage.2009.05.009 · Cited by 165
“BDNF and 5-HT have interactive effects in relation to depression and anxiety, although the precise nature of this relationship is unclear (Martinowich and Lu, 2007).”
BackgroundKarpova, N. N., Lindholm, J., Pruunsild, P., Timmusk, T., & Ċastrén, E. (2008) · European Neuropsychopharmacology · doi:10.1016/j.euroneuro.2008.09.002 · Cited by 163
Lopresti, A. L., Hood, S. D., & Drummond, P. D. (2012) · Journal of Psychopharmacology · doi:10.1177/0269881112458732 · Cited by 151
“Neurogenesis is the process by which new neurons are formed from populations of neural stem or progenitor cells residing in discrete regions of the CNS (Abdipranoto et al., 2008).”
BackgroundInfluentialThe implications of gene–environment interactions in depression: will cause inform cure?
Uher, R. (2008) · Molecular Psychiatry · doi:10.1038/mp.2008.92 · Cited by 159
Reinhart, V., Bove, S. E., Volfson, D., Lewis, D. A., Kleiman, R. J., & Lanz, T. A. (2015) · Neurobiology of Disease · doi:10.1016/j.nbd.2015.03.011 · Cited by 140
“Similarly for MDD, many studies have shown central BDNF elevations in rodents chronically dosed with commonly prescribed antidepressants such as fluoxetine and other SSRIs (Martinowich and Lu, 2008; Miller et al., 2008; Nibuya et al., 1995; Peng et al., 2008).”
BackgroundFrustaci, A., Pozzi, G., Gianfagna, F., Manzoli, L., & Boccia, S. (2008) · Neuropsychobiology · doi:10.1159/000182892 · Cited by 138
Correia, A. S., Cardoso, A., & Vale, N. (2023) · Pharmaceutics · doi:10.3390/pharmaceutics15082081 · Cited by 155
“Additionally, both serotonin and BDNF contribute to the modulation of synaptic connections and structural changes in the brain during neuroplasticity, both being important in the context of mood disorders such as depression [94].”
BackgroundMechanisms of Action and Persistent Neuroplasticity by Drugs of Abuse
Korpi, E. R., den Hollander, B., Farooq, U., Vashchinkina, E., Rajkumar, R., Nutt, D. J., Hyytiä, P., & Dawe, G. S. (2015) · Pharmacological Reviews · doi:10.1124/pr.115.010967 · Cited by 148
A role for the BDNF gene Val66Met polymorphism in schizophrenia? A comprehensive review
Notaras, M. J., Hill, R., & van den Buuse, M. (2015) · Neuroscience & Biobehavioral Reviews · doi:10.1016/j.neubiorev.2014.12.016 · Cited by 150
Balaratnasingam, S., & Janča, A. (2012) · Pharmacology & Therapeutics · doi:10.1016/j.pharmthera.2012.01.006 · Cited by 148
Scattoni, M. L., Martire, A., Cartocci, G., Ferrante, A., & Ricceri, L. (2013) · Behavioural Brain Research · doi:10.1016/j.bbr.2012.12.028 · Cited by 128
Unfolding the Role of BDNF as a Biomarker for Treatment of Depression
Rana, T., Behl, T., Sehgal, A., Srivastava, P., & BUNGAU, S. G. (2020) · Journal of Molecular Neuroscience · doi:10.1007/s12031-020-01754-x · Cited by 147
“Neuroinflammation is a complex and synchronized process, involving different glial cells in the CNS and immune cells in the peripheral nervous system (Yang and Zhou 2019).”
BackgroundInfluentialPredicting recovery in acute poststroke aphasia
Hillis, A. E., Beh, Y. Y., Sebastian, R., Breining, B., Tippett, D. C., Wright, A., Saxena, S., Rorden, C., Bonilha, L., Basilakos, A., et al. (2018) · Annals of Neurology · doi:10.1002/ana.25184 · Cited by 142
Qin, X.-Y., Cao, C., Cawley, N. X., Liu, T.-T., Yuan, J., Loh, Y. P., & Cheng, Y. (2016) · Molecular Psychiatry · doi:10.1038/mp.2016.62 · Cited by 142
The Endocannabinoid System and Physical Exercise
Matei, D., Trofin, D., Iordan, D. A., Onu, I., Condurache, I., Ionițe, C., & Buculei, I. (2023) · International Journal of Molecular Sciences · doi:10.3390/ijms24031989 · Cited by 143
“Decreased BDNF levels have been reported in people under great psychological stress [148].”
Brain‐derived neurotrophic factor and post‐stroke depression
Zhang, E., & Liao, P. (2019) · Journal of Neuroscience Research · doi:10.1002/jnr.24510 · Cited by 140
Beauchaine, T. P., Neuhaus, E., Zalewski, M., Crowell, S. E., & Potapova, N. (2011) · Development and Psychopathology · doi:10.1017/s0954579411000459 · Cited by 129
“This is noteworthy because reuptake of 5-HT from the synaptic cleft to presynaptic terminals is mediated entirely by 5-HTT (see Martinowich & Lu, 2007).”
BackgroundMolteni, R., Cattaneo, A., Calabrese, F., Macchi, F., Olivier, J. D. A., Racagni, G., Ellenbroek, B. A., Gennarelli, M., & Riva, M. A. (2010) · Neurobiology of Disease · doi:10.1016/j.nbd.2009.12.014 · Cited by 128
“, 2009), and a close link between serotonin and the neurotrophin has been suggested (Martinowich and Lu, 2008; Mattson et al., 2004).”
InfluentialLifestyle Factors and Mental Health.
Zaman, R., Hankir, A. K., & Jemni, M. (2019) · PubMed · Cited by 139
Brain Insulin Dysregulation: Implication for Neurological and Neuropsychiatric Disorders
Ghasemi, R., Dargahi, L., Haeri, A., Moosavi, M., Mohamed, Z., & Ahmadiani, A. (2013) · Molecular Neurobiology · doi:10.1007/s12035-013-8404-z · Cited by 138
“Disturbances of 5-HT signaling is implicated in the psychiatric disorders such as depression and drugs affecting the synaptic concentration of serotonin like 5-HT reuptake inhibitors are widely used in the treatment of depression and anxiety (reviewed in [237]).”
BackgroundThe Role of BDNF as a Biomarker in Cognitive and Sensory Neurodegeneration
Pisani, A., Paciello, F., VECCHIO, V. D., Malesci, R., Corso, E. D., Cantone, E., & Fetoni, A. R. (2023) · Journal of Personalized Medicine · doi:10.3390/jpm13040652 · Cited by 138
“Indeed, studies have suggested that decreased BDNF levels can be associated with depression onset and progression [6,168].”
BackgroundWang, R., Li, Y., Xu, Y., Li, Y., Wu, H., Guo, H., Zhang, J., Zhang, J., Pan, X., & Li, X.-J. (2009) · Progress in Neuro-Psychopharmacology and Biological Psychiatry · doi:10.1016/j.pnpbp.2009.10.016 · Cited by 138
Marcon, M., Herrmann, A. P., Mocelin, R., Rambo, C. L., Koakoski, G., de Abreu, M. S., Conterato, G. M. M., Kist, L. W., Bogo, M. R., Zanatta, L. C. B., et al. (2016) · Psychopharmacology · doi:10.1007/s00213-016-4408-5 · Cited by 138
“2015), and the effects of reuptake inhibitors involve changes in synaptic plasticity that develop gradually over long-term use (Santarelli et al. 2003; Djavadian 2004; Martinowich and Lu 2007).”
BackgroundBrain-derived neurotrophic factor ( BDNF) gene: no major impact on antidepressant treatment response
Domschke, K., Lawford, B., Laje, G., Berger, K., Young, R., Morris, P., Deckert, J., Arolt, V., McMahon, F. J., & Baune, B. T. (2010) · The International Journal of Neuropsychopharmacology · doi:10.1017/s1461145709000030 · Cited by 122
“…as being reciprocal, with BDNF on the one hand promoting development and function of serotonergic neurons and serotonin as amplified by SSRIs on the other hand increasing BDNF transcription via cAMP responsive element binding protein (CREB) phosphorylation (as reviewed by Martinowich & Lu, 2008).”
Therapeutic Effects of Phytochemicals and Medicinal Herbs on Depression
Lee, G., & Bae, H. (2017) · BioMed Research International · doi:10.1155/2017/6596241 · Cited by 133
“In addition, the childhood adversity may contribute to the disease, especially if epigenetic changes are involved [4, 5].”
BackgroundMechanisms of Panax ginseng action as an antidepressant
Jin, Y., Cui, R., Zhao, L., Fan, J., & Li, B. (2019) · Cell Proliferation · doi:10.1111/cpr.12696 · Cited by 133
Raphe-mediated signals control the hippocampal response to SRI antidepressants via miR-16
Launay, J. M., Mouillet-Richard, S., Baudry, A., Pietri, M., & Kellermann, O. (2011) · Translational Psychiatry · doi:10.1038/tp.2011.54 · Cited by 118
The effect of insomnia on development of Alzheimer’s disease
Sadeghmousavi, S., Eskian, M., Rahmani, F., & Rezaei, N. (2020) · Journal of Neuroinflammation · doi:10.1186/s12974-020-01960-9 · Cited by 133
Vines, A., Delattre, A. M., Lima, M. M. S., Rodrigues, L. S., Suchecki, D., Machado, R. B., Tufik, S., Pereira, S. I. R., Zanata, S. M., & Ferraz, A. C. (2011) · Neuropharmacology · doi:10.1016/j.neuropharm.2011.06.017 · Cited by 129
“…resulted, primarily, in the increase of cortical and hippocampal BDNF expressions, which mediate events of cell survival, growth and plasticity (Martinowich and Lu, 2008) culminating in the modulations of binding and expressions of 5-HT1A receptors and perhaps preventing the degradation of…”
BackgroundCsölle, C., Baranyi, M., Zsilla, G., Kittel, Á., Gölöncsér, F., Illes, P., Papp, E., Vizi, E. S., & Sperlágh, B. (2013) · PLoS ONE · doi:10.1371/journal.pone.0066547 · Cited by 128
“BDNF is critical for the normal development and function of central 5-HT neurons and the elaboration of behaviors that depend on the activity of these neurons [103,104,105].”
BackgroundCarniel, B. P., & da Rocha, N. S. (2020) · Progress in Neuro-Psychopharmacology and Biological Psychiatry · doi:10.1016/j.pnpbp.2020.110151 · Cited by 127
New Atypical Antipsychotics in the Treatment of Schizophrenia and Depression
Orzelska‐Górka, J., Mikulska, J., Wiszniewska, A., & Biała, G. (2022) · International Journal of Molecular Sciences · doi:10.3390/ijms231810624 · Cited by 129
“However, this hypothesis requires further research [27,28].”
Chronically Restricted or Disrupted Sleep as a Causal Factor in the Development of Depression
Meerlo, P., Havekes, R., & Steiger, A. (2015) · Current topics in behavioral neurosciences · doi:10.1007/7854_2015_367 · Cited by 129
“Moreover, the BDNF and serotonin signaling systems mutually affect each other (Martinowich and Lu 2008).”
BackgroundAerobic exercise upregulates the BDNF-Serotonin systems and improves the cognitive function in rats
Pietrelli, A., Matković, L., Vacotto, M., López‐Costa, J. J., Basso, N., & Brusco, A. (2018) · Neurobiology of Learning and Memory · doi:10.1016/j.nlm.2018.05.007 · Cited by 127
Blázquez, E., Hurtado-Carneiro, V., Ayuso, Y. L. B., Velázquez, E., García‐García, L., Gómez-Oliver, F., Ruiz‐Albusac, J. M., Ávila, J., & Pozo, M. A. (2022) · Frontiers in Endocrinology · doi:10.3389/fendo.2022.873301 · Cited by 125
Rantamäki, T., Vesa, L., Antila, H., Di Lieto, A., Tammela, P., Schmitt, A., Lesch, K.-P., Rios, M., & Castrén, E. (2011) · PLoS ONE · doi:10.1371/journal.pone.0020567 · Cited by 124
“serotonergic innervation [40,41].”
Neurobiology of depression: A neurodevelopmental approach
Lima-Ojeda, J. M., Rupprecht, R., & Baghai, T. C. (2018) · The World Journal of Biological Psychiatry · doi:10.1080/15622975.2017.1289240 · Cited by 104
“Also, a complex relation between BDNF–TrkB and 5-HT transmission and function has been observed (Martinowich & Lu 2008).”
BackgroundBaeken, C., & De Raedt, R. (2011) · Dialogues in Clinical Neuroscience · doi:10.31887/dcns.2011.13.1/cbaeken · Cited by 108
Molendijk, M. L., Haffmans, J. P. M., Bus, B. A. A., Spinhoven, P., Penninx, B. W. J. H., Prickaerts, J., Voshaar, R. C. O., & Elzinga, B. M. (2012) · PLoS ONE · doi:10.1371/journal.pone.0048046 · Cited by 100
“It is well established that 5-HT and BDNF interact with each other and it has been suggested that these factors together have regulatory functions in neuronal functioning and neuronal plasticity [26,27].”
BackgroundPharmacometabolomic mapping of early biochemical changes induced by sertraline and placebo
Kaddurah-Daouk, R., Bogdanov, M. B., Wikoff, W. R., Zhu, H., Boyle, S. H., Churchill, E., Wang, Z., Rush, A. J., Krishnan, R. R., Pickering, E., et al. (2013) · Translational Psychiatry · doi:10.1038/tp.2012.142 · Cited by 101
Functional Role of BDNF Production from Unique Promoters in Aggression and Serotonin Signaling
Maynard, K. R., Hill, J. L., Calcaterra, N. E., Palko, M. E., Kardian, A., Paredes, D., Sukumar, M., Adler, B. D., Jimenez, D. V., Schloesser, R. J., et al. (2015) · Neuropsychopharmacology · doi:10.1038/npp.2015.349 · Cited by 120
Self-citationda Silva, T. F., Glória, R. D. A., Americo, M. F., Freitas, A. D. S., de Jesus, L. C. L., Barroso, F. A. L., Laguna, J. G., Coelho-Rocha, N. D., Tavares, L. M., le Loir, Y., et al. (2024) · Probiotics and Antimicrobial Proteins · doi:10.1007/s12602-024-10247-x · Cited by 117
“These substances control neural excitatory-inhibitory balance, mood, cognitive functions, learning, and memory processes [317–319].”
Metadata
- Authors
- Martinowich, K., & Lu, B.
- Affiliations
- National Institutes of Health (US)
- Corresponding author
- Lu, Bai
- Venue
- Neuropsychopharmacology
- Published
- 2007-09-19
- Volume
- 33
- Issue
- 1
- Pages
- 73-83
- ISSN
- 0893-133X (ISSN-L)
- 1740-634X
- OpenAlex
- W2067657652
- Cited by
- 793
- References
- 133
- Citations by year
- 2026: 34 · 2025: 42 · 2024: 48 · 2023: 38 · 2022: 58 · 2021: 67 · 2020: 52 · 2019: 54 · 2018: 44 · 2017: 43 · 2016: 40 · 2015: 39 · 2014: 36 · 2013: 36 · 2012: 43
- FWCI
- 2.90
- Type
- journal article
- Language
- en
- Open access
- closed
- Licence
- www.springer.com/tdm (tdm)
- Locations
- Neuropsychopharmacology (publishedVersion)
- PubMed (publishedVersion)
- Topics
- Health Sciences › Medicine › Pharmacology (medical) › Treatment of Major Depression
- Life Sciences › Neuroscience › Cellular and Molecular Neuroscience › Neurotransmitter Receptor Influence on Behavior
- Life Sciences › Neuroscience › Cellular and Molecular Neuroscience › Nerve injury and regeneration
- Keywords
- brain-derived neurotrophic factor, serotonin, mood disorders, depression, anxiety, selective serotonin reuptake inhibitors, antidepressant effects, synaptic plasticity, neurogenesis, serotonergic neurons, serotonin transporter, genetic epistasis, emotional behavior
- MeSH terms
- Animals, Gene Expression Regulation, Humans, Neurons, Serotonin, Brain-Derived Neurotrophic Factor, Mood Disorders
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.